Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Ovarian Neoplasms 1Osteoporosis 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1

Interventions

pembrolizumab 5Cyclophosphamide 5Nivolumab 4Psychiatric Rehabilitation 3Paclitaxel 3Flow Cytometry 3Filgrastim 3valspodar 2sargramostim 2fludarabine 2epacadostat 2durvalumab 2atezolizumab 2aldesleukin 2Surveys and Questionnaires 2Microarray Analysis 2Methylprednisolone 2Melphalan 2Interleukin-2 2Immunologic Techniques 2Early Intervention, Educational 2Dexamethasone 2Dasatinib 2Carboplatin 2Biopsy 2Azacitidine 2Analgesia 2Amifostine 2Alemtuzumab 2vocimagene amiretrorepvec 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Calcium Citrate × Gynecologic × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡